Jareka Anderson
Nurse Practitioner · Ennis, TXNPI 1306300090
Payments from drug & device makers
Across 230 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$755
- AbbVie$556
- Lilly USA, LLC$293
- Corium, LLC$271
- Corcept Therapeutics$262
- Pfizer$258
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,922100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 51 | $755 |
| AbbVie | 27 | $556 |
| Lilly USA, LLC | 24 | $293 |
| Corium, LLC | 15 | $271 |
| Corcept Therapeutics | 16 | $262 |
| Pfizer | 12 | $258 |
| Dexcom, Inc. | 12 | $208 |
| Otsuka America Pharmaceutical, Inc. | 7 | $147 |
| Ironshore Pharmaceuticals Inc. | 7 | $142 |
| Tris Pharma Inc | 7 | $101 |
| Noven Therapeutics, LLC | 6 | $99 |
| Boehringer Ingelheim | 6 | $95 |
| Analog Devices Inc. | 4 | $68 |
| Bolton Medical Inc | 1 | $62 |
| Amgen | 4 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $34 |
| Exact Sciences | 2 | $32 |
| Bayer | 2 | $30 |
| Johnson & Johnson | 2 | $26 |
| Cranial Technologies, Inc | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Medtronic | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Cequr Corporation | 1 | $16 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,934 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 114 | $200,739 |
| JardianceEmpagliflozin | 100 | $164,693 |
| FarxigaDapagliflozin Propanediol | 47 | $61,113 |
| LinzessLinaclotide | 27 | $38,548 |
| EliquisApixaban | 31 | $32,109 |
| MyrbetriqMirabegron | 19 | $25,839 |
| Nurtec OdtRimegepant Sulfate | 12 | $24,105 |
| WegovySemaglutide | 16 | $23,664 |
| Novolog FlexpenInsulin Aspart | 16 | $8,415 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $7,892 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $7,548 |
| Gabapentin | 199 | $4,670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 120 | $3,883 |
| Levemir FlexpenInsulin Detemir | 15 | $2,671 |
| Levocetirizine Dihydrochloride | 176 | $2,652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $755 | $224,403130 claims |
| Boehringer IngelheimJardiance | $95 | $164,693100 claims |
| AstraZenecaFarxiga, Symbicort | $16 | $68,66165 claims |
| PfizerEliquis, Nurtec Odt | $258 | $56,21443 claims |
| AbbVieLinzess, Synthroid | $556 | $39,29139 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Ennis
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.